Correction to: British Journal of Cancer (2007) 96, 1293–1301. doi:10.1038/6603696
In the abstract of the above paper, a peptide with correct sequence (TLMKKDKYTL) is mentioned. This sequence should also appear in Table 1 as the sequence of peptide 60031. Unfortunately, an incorrect sequence (ALSPASSRSV) was included in Table 1 (all other data in the respective line of the table are correct and refer to peptide TLMKKDKYTL).
The corrected Table 1 is shown below.
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
Additional information
The online version of the original article can be found at 10.1038/sj.bjc.6603696
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Schmitz, M., Temme, A., Senner, V. et al. Erratum: Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy. Br J Cancer 96, 1928 (2007). https://doi.org/10.1038/sj.bjc.6603802
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6603802
